QTTB FY 2020 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+62.2% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$130M-4821.0% margin

Net Income

-$129M-4762.9% margin

EPS (Diluted)

$-50.46

Cash Flow

Operating Cash Flow

-$94M

Free Cash Flow

-$98M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$264M

Total Liabilities

$68M

Stockholders' Equity

$196M

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+62.2%
Gross Profit	$3M	$2M	+62.2%
Operating Income	-$130M	-$110M	-18.5%
Net Income	-$129M	-$104M	-23.8%